TrialDiabetologia2021

Safety and cost-effectiveness of individualised screening for diabetic retinopathy: the ISDR open-label, equivalence RCT.

Deborah M Broadbent et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.